Biologics and Biosimilars World MarketsSacramento Bee… 6.43.4 Genotropin (somatropin) 231 6.43.5 Herceptin (trastuzumab) 232 6.43.6 Humira (adalimumab) 232 6.43.7 Neulasta (pegfilgrastim) 233 6.43.8 Neupogen (filgrastim) 233 6.43.9 Remicade (inflixim…
|
Save a life this Sunday
Palm Beach Post After all, Gift of Life (giftoflife.org) — which has been headquartered in South Florida since 1999 — is the only bone marrow donor registry founded by the recipient of a bone-marrow transplantation: leukemia survivor Jay Feinberg. When Feinberg, 45 … |
TotipotentRX and ThermoGenesis Achieve Bone Marrow Stem Cell Transplant …GlobeNewswire (press release)RANCHO CORDOVA, Calif., LOS ANGELES and NEW DELHI, India, Feb. 3, 2014 (GLOBE NEWSWIRE) — ThermoGenesis Corp. (Nasdaq:KOOL) a cellular therapy medi…
TotipotentRX and ThermoGenesis Achieve Bone Marrow Stem Cell Transplant …NASDAQRANCHO CORDOVA, Calif., LOS ANGELES and NEW DELHI, India, Feb. 3, 2014 (GLOBE NEWSWIRE) — ThermoGenesis Corp. (Nasdaq:KOOL) a cellular therapy medical device company and …
TotipotentRX and ThermoGenesis Achieve Bone Marrow Stem Cell Transplant …MarketWatchRANCHO CORDOVA, Calif., LOS ANGELES and NEW DELHI, India, Feb 03, 2014 (GLOBE NEWSWIRE via COMTEX) — ThermoGenesis Corp. (NASDAQ:KOOL) a cellular therapy medical dev…
India.Com HealthWorld Cancer Day 2014: New cancer cases to increase five-fold by 2025India.Com HealthWith a million new cases being reported every year, cancer seems to be tightening its grip on India. Experts say the incidence of the killer disease is…
Heart Failure Study Proves Serial Testing of ST2 Can Help Improve Patient Care …MarketWatchSAN DIEGO, Feb 03, 2014 (BUSINESS WIRE) — Critical Diagnostics announced today that results of a Massachusetts General Hospitalbiomarker-guided therapy study …
|
Heart Failure Study Proves Serial Testing of ST2 Can Help Improve Patient Care …
Business Wire (press release) Study shows ST2 accurately reflects a patient’s changing condition, adding prognostic value over and above clinical variables plus NT-proBNP and high sensitive troponin. Evaluating Galectin-3 by BG Medicine (NASDAQ:BGMD) in the same study cohort … |
Multiple Sclerosis — KOL Insight and Consensus Outlook ModulesSYS-CON Media (press release)Rebif (interferon beta-1a; Merck Serono) forecast2.14.Extavia (interferon beta-1b; Novartis) forecast2.15.Lemtrada (alemtuzumab; Genzyme/Sanofi) forecast2.16.La…
Times of IndiaCancer cases set to rise by half by 2030: UNTimes of IndiaCancers of the breast, colorectum and prostate were more typical of the industrialized world, said the report, and those of the liver, stomach and oesophagus more common in low-inc…